Chapter 1.       GLOBAL PRURITUS THERAPEUTIC MARKET  – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.       GLOBAL PRURITUS THERAPEUTIC MARKET  – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

 2.3.1. Impact during 2023 - 2030

  2.3.2. Impact on Supply – Demand

Chapter 3.       GLOBAL PRURITUS THERAPEUTIC MARKET  – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.      GLOBAL PRURITUS THERAPEUTIC MARKET  - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatorycenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5.     GLOBAL PRURITUS THERAPEUTIC MARKET   - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6.   GLOBAL PRURITUS THERAPEUTIC MARKET – By Type

6.1. Oncological pruritus

6.2. Renal pruritus

6.3. Cholestatic pruritus

6.4. Hematologic pruritus

6.5. Endocrine pruritus

Chapter 7.       GLOBAL PRURITUS THERAPEUTIC MARKET  – By Region

7.1. North America

7.2. Europe

7.3. Asia-P2acific

7.4. Latin America

7.5. The Middle East

7.6. Africa

Chapter 8.       GLOBAL PRURITUS THERAPEUTIC MARKET  – By Companies

8.1. Companies 1

8.2. Companies 2

8.3. Companies 3 

8.4. Companies 4

8.5. Companies 5

8.6. Companies 6

8.7. Companies 7

8.8. Companies 8

8.9. Companies 9

8.10. Companies 10